Boji Medical Technology Co Ltd
300404
Company Profile
Business description
Boji Medical Technology Co Ltd is engaged in offering outsourcing services for drug research and development. Its services include drug research and development, including new drug research and activity screening, pharmaceutical research, drug evaluation Price, clinical research, technological achievements transformation services, and pre-clinical independent research and development.
Contact
Nanxiang 1st Road
Building No. 62
Science City, Huangpu District
Guangdong Province
Guangzhou510640
CHNT: +86 2035647628
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
1,198
Stocks News & Analysis
stocks
Chart of the Week: Recent selloffs in this ASX sector opens doors to opportunity
Ongoing rate hikes have investors spooked.
stocks
ASX dividend champions: Stocks, ETFs and LICs
Mark and Shani run through lessons for ASX stocks, ETFs and LICs that have delivered over the past decade.
stocks
SpaceX’s IPO filing: Big spending, big losses
The first public financials from Elon Musk’s company highlight Starlink’s revenue power and increased spending on AI.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,841.30 | 9.00 | -0.10% |
| CAC 40 | 8,117.42 | 135.66 | 1.70% |
| DAX 40 | 24,737.24 | 336.59 | 1.38% |
| Dow JONES (US) | 50,009.35 | 645.47 | 1.31% |
| FTSE 100 | 10,432.34 | 101.79 | 0.99% |
| HKSE | 25,504.11 | 147.01 | -0.57% |
| NASDAQ | 26,270.36 | 399.65 | 1.54% |
| Nikkei 225 | 61,734.98 | 1,930.57 | 3.23% |
| NZX 50 Index | 12,878.07 | 117.04 | 0.92% |
| S&P 500 | 7,432.97 | 79.36 | 1.08% |
| S&P/ASX 200 | 8,621.60 | 6.40 | -0.07% |
| SSE Composite Index | 4,148.19 | 13.99 | -0.34% |